| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/11/2002 | WO2000062067A9 Novel transduction molecules and methods for using same |
| 07/11/2002 | WO2000061231A3 Medical use |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091265 4-phenyl-pyridine derivatives |
| 07/11/2002 | US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 07/11/2002 | US20020091259 Compounds useful as reversible inhibitors of cathepsin S |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | US20020091150 Carbamic acid derivatives |
| 07/11/2002 | US20020091145 Behavior chemotherapy |
| 07/11/2002 | US20020091141 Treating serotonin-related central nervous system disorders |
| 07/11/2002 | US20020091140 Method of treating and preventing migraine headaches |
| 07/11/2002 | US20020091136 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 07/11/2002 | US20020091135 Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| 07/11/2002 | US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | US20020091118 Psychotherapeutic agents. |
| 07/11/2002 | US20020091117 Psychotherapeutic agents. |
| 07/11/2002 | US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | US20020091108 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091104 Protein tyrosine phosphatases inhibitors, especially as antidiabetic agents |
| 07/11/2002 | US20020091094 Glutamic acid decarboxylase (GAD) based delivery system |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091087 Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020091075 Administering a kappa opioid receptor antagonist |
| 07/11/2002 | US20020091072 Endothelin converting enzymes and the amyloid beta peptide |
| 07/11/2002 | US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090441 Phytopharmaceutical food products or integrators |
| 07/11/2002 | US20020090406 Tahitian noni juice on COX-1 and COX-2 and tahitian noni juice as a selective COX-2 inhibitor |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | DE10064195A1 Verwendung einer Zusammensetzung zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Use of a composition for the stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433492A1 Transcription activation complex comprising arnt 1 to 3 and a transcriptional regulatory factor and uses thereof |
| 07/11/2002 | CA2433446A1 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | CA2433384A1 Neurotrophic tacrolimus analogs |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2432959A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432136A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | CA2431545A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221480A1 Polypeptide humanin inhibiting nerve cell death |
| 07/10/2002 | EP1221443A1 Substituted imidazolidinone derivatives |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220945A2 Screen for axon viability |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220915A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220870A1 Metal-binding compounds and uses therefor |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220853A1 Piperidine derivatives as serotonine reuptake inhibitors |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220672A1 Medicament for treatment of neuropathies |
| 07/10/2002 | EP1220662A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 07/10/2002 | CN1358095A Method for treating chronic pain uisng MEK inhibitors |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358093A Decursinol or derivative thereof as analgesic agent |
| 07/10/2002 | CN1358092A Pharmaceutical composition containing sibutramine and orlistat |
| 07/10/2002 | CN1358091A Estrogen receptor-beta ligands |
| 07/10/2002 | CN1358090A Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 07/10/2002 | CN1358087A Timed dual release dosage forms comprising short acting hypnotic or salt thereof |